Jasper Therapeutics, Inc. (JSPRW)
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States.
$0.01+0.00%
StockGlow Score
Neutral
BearishBullish
1 year ago-48.0%
The outlook
Jasper Therapeutics, Inc. currently reads as neutral based on 48% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
52-week range48% of the way from its 52-week low to high
Market cap
—
52-wk high
$0.01
52-wk low
$0.01
50-day avg
—
200-day avg
—
Trailing P/E
—